Paul G Auwaerter is the Sherrilyn and Ken Fisher Professor of Medicine at the Johns Hopkins University School of Medicine, serving as the Clinical Director for the Division of Infectious Diseases and Director of the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases.

He serves as the Executive Director of the Johns Hopkins Point of Care-Information Technology (POC-IT) Center producing the Johns Hopkins ABX (Antibiotic), JH HIV, JH Osler, JH Psychiatry and JH Diabetes Guides. Dr. Auwaerter serves as Editor-in-Chief of the ABX Guide. Over the last 20 years, it has grown to be a standard reference for ID-related clinical decision support and rational antimicrobial management. Dr. Auwaerter’s research and clinical interests include improving the diagnosis and care for patients with Lyme disease and other tick-borne infections as well as surgical infections, Epstein-Barr virus, respiratory diseases, and antibiotics resistance. Dr. Auwaerter has led the development of therapeutic guidance for COVID-19 in the Johns Hopkins Medical Institutions, and facilitating monkeypox care and treatment. He is a Past President of the Infectious Diseases Society of America (IDSA), the largest professional society worldwide related to infectious diseases.

Dr. Katharine Bar is an Assistant Professor of Medicine at the University of Pennsylvania and directs the Virus and Reservoirs Core of the Penn Center for AIDS Research. At Penn, Dr. Bar is an Infectious Diseases provider and a translational physician-scientist studying novel approaches to HIV prevention and cure.

Dr. Bell is an Assistant Professor of Medicine in the divisions of Infectious Disease and Pulmonary/Critical Care Medicine at the University of Virginia. He is also Vice Chair for Faculty Affairs at the UVA Department of Medicine and Director of the UVA Summer Medical Leadership Program (a medical school preparatory program for under-represented and disadvantaged students). Dr. Bell joined the faculty in 2017 after completing a critical care fellowship at the National Institutes of Health. Prior to that he completed internal medicine residency at the Massachusetts General Hospital—where he was a chief resident—and infectious disease fellowship at the combined Massachusetts General Hospital/Brigham and Women’s Hospital program. Dr. Bell is co-founder of Owl Peak Labs, a Biotechnology startup based in Charlottesville, VA working to create innovative in-home colorectal cancer screening solutions.

Helen Boucher, MD, is the Dean and Professor of Medicine at Tufts University School of Medicine and Chief Academic Officer of the Tufts Medicine Health System. An active Infectious Diseases physician, she was previously Chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center, and Director of the Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance (Levy CIMAR).

Dr. Boucher’s clinical interests include infections in immunocompromised patients and S. aureus infections. Her research interests focus on S. aureus and the development of new anti-infective agents. She is the Chair of the National Institutes of Health (NIH) Antibacterial Resistance Leadership Group (ARLG) Innovations Working Group, and serves on the Executive and Steering Committees. Dr. Boucher is the author or coauthor of numerous abstracts, chapters, and peer-reviewed articles, which have been published in such journals as The New England Journal of Medicine, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, and The Annals of Internal Medicine. She is Associate Editor of Antimicrobial Agents and Chemotherapy, Editor of the Sanford Guide to Antimicrobial Therapy, and Infectious Diseases Clinics of North America.

In 2015, Dr. Boucher was appointed a voting member of the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB), and elected Treasurer of the Infectious Diseases Society of America (IDSA). She was awarded the IDSA Society Citation Award in October 2015 and the Maxwell Finland Award in 2022. Dr. Boucher serves as Chair of the Board of Trustees of The College of the Holy Cross and as Chair of the Board of Trustees of the Physicians of Tufts Medical Center.

Charles L. Daley, M.D., is Chief of the Division of Mycobacterial and Respiratory Infections at National Jewish Health (NJH) and Professor of Medicine at NJH, the University of Colorado, and Icahn School of Medicine at Mount Sinai. Dr. Daley has served on and chaired expert panels for the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Infectious Diseases Society of America and American Thoracic Society. He Chaired the revision of the multi-society sponsored NTM Treatment Guideline. Dr. Daley was the inaugural chair of the United States Bronchiectasis Research Registry. For his work with MDR-TB he was awarded the World Lung Health Award by the American Thoracic Society. He was previously Associate Editor of the American Journal of Respiratory and Critical Care Medicine and The European Respiratory Journal. His academic interests include TB global health policy and clinical and translational research related to TB, NTM infections and bronchiectasis.

Carlos del Rio, MD is a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine and Executive Associate Dean for Emory at Grady. He is also Professor of Global Health and Professor of Epidemiology at the Rollins School of Public Health. He is co-Director of the Emory Center for AIDS Research (CFAR) and co-PI of the Emory-CDC HIV Clinical Trials Unit and the Emory Vaccine and Treatment Evaluation Unit. Dr. del Rio’s research focuses on the early diagnosis, access to care, engagement in care, compliance with antiretrovirals and the prevention of HIV infection.  He has worked for over a decade with hard-to-reach populations including substance users to improve outcomes of those infected with HIV and to prevent infection with those at risk. He is also interested in the translation of research findings into practice and policy.  

  During the COVID-19 pandemic Dr. del Rio has been a leader locally and nationally, doing research, developing policies, writing scientific publications and making countess media appearances. Dr. del Rio has advised municipal, state, and national leaders including Atlanta Mayor Keisha Lance Bottoms, Tyler Perry Studios, the NCAA, the USTA, Delta Air Lines, Truist Bank, the Atlanta Symphony Orchestra and the Atlanta Opera among others. He also serves on the national advisory committee of the COVID Collaborative, which focuses on developing consensus recommendations and engaging with U.S. leaders on effective policy and coronavirus response. Lastly, Dr. del Rio is an investigator on the Moderna COVID-19 vaccine clinical trial as well as on the ACTT Studies that led to the approval of Remdesivir among other drugs.

Dr. Daniel Diekema is Vice Chair for Research and Director of the Division of Infectious Diseases in the Department of Medicine at Maine Medical Center in Portland, Maine. He is also a Professor Emeritus of Internal Medicine at the University of Iowa, where he served as a director for the Division of Infectious Diseases from 2010-2021. Dr. Diekema received his MD at Vanderbilt University in 1989. He did his residency in internal medicine at the University of Virginia (1989-1992). He did his fellowships in infectious diseases (1992-1995) and medical microbiology (1998-2000) at the University of Iowa. Also while at the University of Iowa, he received his master of science in preventive medicine.

  As a hospital epidemiologist, infectious diseases clinician and a clinical microbiologist, he has studied and published extensively on the epidemiology of antimicrobial resistance and health care-associated infections, with particular emphasis on drug-resistant pathogens and health care-associated fungal infections. Dr. Diekema is a past president of the Society for Healthcare Epidemiology of America, and was also a member and co-chair of the CDC Healthcare Infection Control Practices Advisory Committee.

Dr. Marlene Durand is an infectious disease (ID) physician at Massachusetts General Hospital (MGH) and Massachusetts Eye and Ear (MEE). After graduating from Harvard Medical School and completing her residency and fellowship at MGH, she joined the staff at MGH and has been there since. She has been nominated five times for the McGovern Award for clinical excellence at MGH, received a Faculty Teaching Award from the ID Fellows in the combined MGH/Brigham & Women’s Hospital program, and received the 2022 Kenneth Kaplan Award as “Clinician of the Year” from the Massachusetts ID Society. In addition to seeing patients at MGH, she has been Director of the ID Service at MEE for over 20 years and has cared for several thousand patients with eye or ENT infections. She has contributed over 140 articles and book chapters about eye or ENT infections. She is also a section editor for head and neck infections for UpToDate and author of several topics pertaining to eye and ENT infections for that on-line resource. She is the primary editor of two textbooks, Endophthalmitis and Infections of the Ears, Nose, Throat, and Sinuses.

Marshall J. Glesby is a Professor of Medicine and Population Health Sciences, Director of the HIV Clinical Trials Unit, Associate Chief of the Division of Infectious Diseases, and Vice Chair for Mentoring and Faculty Development in the Department of Medicine at Weill Cornell Medicine. He serves as the Regional Clinical Director of the Northeast Caribbean AIDS Education and Training Center and the Director of the Clinical and Translational Resource Unit Core of the Weill Cornell Clinical and Translational Science Center. Dr. Glesby is a graduate of the Johns Hopkins University School of Medicine and completed his internal medicine residency and infectious diseases fellowship at the Johns Hopkins Hospital.  He also has a Ph.D. in Clinical Investigation from the Johns Hopkins School of Hygiene and Public Health and is board certified in internal medicine and infectious diseases. His research focuses on complications and co-morbidities in people with HIV infection. He has been the Principal Investigator of the CDC tecovirimat expanded access program for MPOX at Weill Cornell, overseeing the treatment of approximately 100 people with proven or suspected MPOX.

Dr. Goff is an Infectious Diseases Specialist, founding member of the Antimicrobial Stewardship Program at The Ohio State University (OSU) Wexner Medical Center, Professor of Pharmacy Practice at The OSU College of Pharmacy and Antibiotic Stewardship Ambassador for The OSU Global One Health Institute in Columbus Ohio, USA. Dr. Goff received her Bachelor of Pharmacy, Doctor of Pharmacy degrees and residency from the University of Illinois at Chicago.

Dr. Goff is one of twenty-five global health experts selected by the World Health Organization (WHO) to implement antimicrobial stewardship programs in low middle-income countries. She is the international advisor to the Federation of Infectious Diseases Society of South Africa and Program Director for the Train the Trainer Antibiotic Stewardship Mentoring Program founded in 2012 for South African pharmacists. Her Train the Trainer program has been implemented in Lebanon and six Latin American countries. She received the OSU 2019 Distinguished International Outreach and Engagement Award for her work in South Africa and the 2017 American College of Clinical Pharmacy Global Health Award. Dr. Goff is a 2016 TEDx Columbus speaker on antibiotics “just in case” there’s infection with over 25,500 views on YouTube. She conducted the first US outpatient dental antibiotic stewardship study in 2021 with private practice dentists.

Dr. Andy Hale received his undergraduate education at Middlebury College, then went to medical school at Tufts University School of Medicine. He completed internal medicine residency, chief residency, and infectious diseases fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School. He is now an Infectious Diseases physician at the University of Vermont Medical Center and an avid medical educator and researcher. He is the course director of cardiac, respiratory, and renal pathophysiology at UVM College of Medicine, Infectious Diseases: past, present, and future at Middlebury College, and Comparative Physiology at Mount Desert Island Biological Laboratory. He is an associate program director for the internal medicine residency at UVMMC. His main research interests include medical education, HIV, HCV, and asplenic care.

Dr. Kimberly Hanson is a Professor of Medicine and Pathology at the University of Utah. Administratively, Dr. Hanson serves as the Director of the Immunocompromised Host Infectious Diseases Service and is Section Chief for Clinical Microbiology within ARUP Laboratories. She maintains an active research program that is focused on the development and validation of novel, cost-effective diagnostic tests with a focus on opportunistic infections.

Dr. Harris is an infectious disease physician and epidemiologist whose research interests include emerging pathogens, antimicrobial-resistant bacteria, hospital epidemiology/infection control, epidemiologic methods in infectious diseases and medical informatics. He has published over 280 papers. He has current or has had funding from the NIH, CDC and AHRQ to study antibiotic resistance and hospital epidemiology. He is extremely proud of his mentoring track-record.

Dr. Carl LeBuhn completed medical school, internal medicine residency, chief residency, and infectious diseases fellowship at the University of Iowa. He spent three years on the teaching faculty at the University of Iowa before entering private practice in Paducah, Kentucky in June of 2000. For the past 21 years he has has provided inpatient and outpatient general infectious diseases consultations for western Kentucky and southern Illinois. He has clinical privileges at Baptist Health Paducah, ContinueCare Hospital at Baptist Health Paducah, and Mercy Health Paducah. He and his partner provide HIV/AIDS care to approximately 400 patients through LivWell a federally funded HIV/AIDS organization. He is currently the chair of the Paducah Independent Schools Board of Education and has served on the Board since 2005. 

Dr. Marrazzo holds the C. Glenn Cobbs Endowed Chair and is Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham Heersink School of Medicine (UAB). She is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America (IDSA), and was elected Treasurer of the IDSA in 2021, having served on the board since 2018. She was Chair of the American Board of Internal Medicine Council from 2015-2018.

Dr. Marrazzo has a broad research portfolio that includes the relationships between the vaginal microbiome and female reproductive tract infections, HIV pre-exposure prophylaxis, hormonal contraception, and risk of STI/HIV acquisition. She leads UAB’s participation in the RECOVER trial, funded by NIH to study post-acute sequelae of SARS-CoV-2 infection, and a large clinical trial of the meningococcal Group B vaccine rMenB+OMV NZ (Bexsero) to prevent gonococcal infection. She chairs the Biomedical Science Committee of the HIV Prevention Trial Network, the group tasked with integrating the biomedical science agenda across numerous clinical trials of antiretroviral prevention agents. She is also a Co-PI of the NIH-funded Infectious Disease Clinical Research Consortium that leads the Vaccine Treatment and Evaluation Units as well as NIH-funded STI clinical trials. She has been a leading voice in educating colleagues, the community, and the media during the COVID-19 pandemic.  

Dr. Mitre obtained his medical degree from the Johns Hopkins School of Medicine in 1995. He then completed an internal medicine residency at New York University and an infectious diseases fellowship at the National Institutes of Health. He has been on the faculty of the Uniformed Services University medical school since 2006, where he is a Professor in the Department of Microbiology and Immunology and an attending physician on the inpatient internal medicine and infectious diseases services at the Walter Reed National Military Medical Center.

Disclaimer: Dr. Mitre is teaching at this course in a personal capacity. The views expressed in his presentations are the sole responsibility of the presenter and do not necessarily reflect the views, opinions, or policies of the Uniformed Services University of the Health Sciences, the Department of Defense, or the United States Government.  

Dr. Susanna Naggie, MD, MHS, is an Associate Professor of Medicine with tenure, and currently holds appointments at Duke University School of Medicine, the Durham Veterans Affairs Medical Center and the Duke Clinical Research Institute. She is the Vice Dean for Clinical Research, and currently serves as the Chair of the Hepatitis Transformative Science Group for the AIDS Clinical Trials Group and as a member of the NIH COVID-19 Treatment Guidelines, DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline. Her research has focused on HIV and liver disease including HCV, HBV and fatty liver disease.  

Robin Patel is the Elizabeth P. and Robert E. Allen Professor of Individualized Medicine and the Director of the Infectious Diseases Research Laboratory, Co-Director of the Clinical Bacteriology Laboratory, Vice Chair of Education in the Department of Laboratory Medicine and Pathology, and former Chair of the Division of Clinical Microbiology, at the Mayo Clinic.

Dr. Patel received an undergraduate degree in Chemistry from Princeton University, where she graduated magna cum laude. From there, she obtained a medical degree from McGill University. Afterwards, Dr. Patel completed Internal Medicine Residency and Fellowships in Medical Microbiology and Infectious Diseases at the Mayo Clinic. Since then, she has been involved in setting standards for diagnostic and clinical care of bacterial infections, as evidenced by the (select) positions she has held or holds within the American Society for Microbiology (President), American Board of Pathology (Microbiology Test Writing Committee Member), Clinical and Laboratory Standards Institute (Subcommittee on Antimicrobial Susceptibility Testing Voting Member), National Institutes of Allergy and Infectious Diseases (Council Member), National Board of Medical Examiners (Microbiology/Immunology Test Material Development Committee Chair), Journal of Clinical Microbiology (Associate Editor), and Clinical Infectious Diseases (Associate Editor).

Since the beginning of her tenure at the Mayo Clinic, Dr. Patel has focused her research on bacterial infections. Her work focuses on three major areas: (1) improvement of next-generation diagnostic techniques, (2) understanding the inherent biology of periprosthetic infection, and (3) understanding antibiotic resistance through a clinical lens. She has published over 550 peer-reviewed publications and is supported by the National Institutes of Health and the Centers for Disease Control and Prevention. She is the Director of the Laboratory Center of the Antibacterial Resistance Leadership Group of the National Institutes of Health. In 2022, she received the Mayo Clinic Distinguished Investigator and Hamao Umezawa awards.

Dr. Patel is a passionate educator whose continued commitment to mentorship can be translated into a long list of trainees from around the world; she had dedicated immeasurable hours of teaching to train the next generation of laboratory scientists. She has led the Mayo Clinic Alix School of Medicine Microbiology Course since 2001, and in 2021, she received the Mayo Clinic Distinguished Educator award.

More information can be found at: https://journals.asm.org/doi/full/10.1128/JCM.01259-20  

Andrew Pavia, M.D. is the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases and adjunct Professor of Medicine at the University of Utah. He also serves as Director of Hospital Epidemiology at Primary Children's Medical Center and Associate Director of the Antimicrobial Stewardship Program. He received his MD from Brown University and was a resident and Chief resident in Medicine at Dartmouth. He served as an EIS officer and Preventive Medicine Resident at the Centers for Disease Control and Prevention (CDC) where he worked on diarrheal disease and HIV. He did Pediatric and Adult ID fellowship at the University of Utah.

He was voted “Utahn of the year” by the Salt Lake Tribune for his efforts to advocate for children during the COVID-19 pandemic and was awarded the “Roz McGee Children’s Champion” award by Voices for Utah Children.